IP Library Assignment 067695/0404
Patent Assignment
Reel/Frame 067695/0404

Merger

Recorded: 2024-06-11 Pages: 8
Assignor
CARDINAL ASSOCIATES, INC.
Executed: 2022-12-21
Assignee
ALBION LABORATORIES, INC.
5 PARAGON DRIVE, MONTVALE, NEW JERSEY, 07645
Covered Properties (4)
Use of Methylsulfonylmethane (Msm) to Modulate Microbial Activity
Patent: 8,841,100 →
Application: 13/029,001 →
Publication: US 2011/0136210
Methylsulfonylmethane (Msm) for Treatment of Drug Resistant Microorganisms
Patent: 8,217,085 →
Application: 13/399,921 →
Publication: US 2012/0149672
Methods of Sensitizing Drug Resistant Microorganisms Using Methylsulfonylmethane (Msm)
Patent: 8,546,373 →
Application: 13/458,907 →
Publication: US 2012/0264726
Use of Methylsulfonylmethane (Msm) to Modulate Microbial Activity
Patent: 9,487,749 →
Application: 14/458,148 →
Publication: US 2014/0349375
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 18, 2011
From: BENJAMIN, RODNEY; VARELMAN, JEFFREY; KELLER, ANTHONY L.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 025983/0906 →
Assignment of Assignor's Interest Apr 17, 2012
From: BENJAMIN, RODNEY; VARELMAN, JEFFREY; KELLER, ANTHONY L.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 028058/0806 →
Assignment of Assignor's Interest Nov 16, 2012
From: ABELA PHARMACEUTICALS, INC.
To: CARDINAL ASSOCIATES, INC.
Reel/Frame 029315/0495 →
Assignment of Assignor's Interest Nov 16, 2012
From: CARDINAL ASSOCIATES, INC.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 029315/0549 →
Assignment of Assignor's Interest Jul 2, 2013
From: COZEAN, COLETTE; BENJAMIN, RODNEY; KELLER, ANTHONY; VARELMAN, JEFFREY
To: TANDEM-ABELA DEVELOPMENT GROUP, LLC
Reel/Frame 030731/0650 →
Assignment of Assignor's Interest Jul 2, 2013
From: TANDEM-ABELA DEVELOPMENT GROUP, LLC
To: ABELA PHARMACEUTICALS, INC.
Reel/Frame 030746/0397 →
Assignment of Assignor's Interest Aug 14, 2014
From: BENJAMIN, RODNEY; VARELMAN, JEFFREY; KELLER, ANTHONY L.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 033540/0093 →
Asset Assignment Agreement Jun 11, 2024
From: BIOGENIC INNOVATIONS, LLC
To: CARDINAL ASSOCIATES, INC.
Reel/Frame 067698/0938 →
Security Interest Jul 24, 2026
From: ALBION LABORATORIES, INC.; BALCHEM CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075393/0698 →